Prediction of Premature Outflow of Amniotic Fluid in Preterm Pregnancy
DOI:
https://doi.org/10.61841/15wcmz91Keywords:
Premature Birth, Prognosis, Premature Discharge of Amniotic Fluid, Normalized Intensive Rate, Threat, Risk FactorsAbstract
Premature discharge of amniotic fluid is a complication of pregnancy, characterized by a violation of the integrity of the membranes of the fetus and the discharge of amniotic fluid before labor, regardless of gestational age. The aim of the study is to develop optimal methods for predicting the threat of premature outflow of amniotic fluid in pregnant women. A total of 478 pregnant women were examined to assess risk factors for the development of premature amniotic fluid flow. Retrospectively analyzed 350 stories of pregnant women from 2016 to 2019. Prospectively, under our supervision, there were 128 pregnant women. The main group consisted of 93 pregnant women. The control group consisted of 35 women. All birth histories were studied, and risk factors leading to this pathology were identified. Prospective analysis. We identified risk factors such as stress, bad habits, age, abortion, gynecological diseases, the threat of abortion, and premature discharge of amniotic fluid. We have developed a prognostic matrix according to the anamnesis and clinical symptoms, using the method of normalizing intensive indicators E.N. Shigan. According to this indicator, the computer program was created on January 25, 2019 (Intellectual Property Agency under the Ministry of Justice of the Republic of Uzbekistan, No. DGU 06117). "A program for identifying risk factors in case of the threat of premature discharge of amniotic fluid." We identified and divided pregnant women into 3 groups: The first group included (n = 17) pregnant women with a low probability of premature discharge of amniotic fluid, group 2 (n = 31) had an average probability of an outflow, and group 3 (n = 45) had a high risk. The results of our studies showed that diene conjugates were 2.2 times higher than normal, and malondialdehydes were 1.4 times higher, which certainly can be one of the pathogenetic factors in the thinning of the amniotic membranes, leading to their failure. Based on the foregoing, we also studied the functional state of the endothelium, a 1.3-fold increase in thrombomodulin content, a 1.5-fold increase in von Willebrand factor, a 2.1-fold increase in fibronectin, a 1.3-fold increase in soluble cell adhesion molecules, and a 1.3-fold increase in vascular cell adhesion molecule 1.1 times. From the cytokine status, a significant increase in the content of proinflammatory cytokines was detected: interleukin 2.9 times, tumor necrosis factor 2.6 times, C-3 1.9 times, and C-4 2.0 times in patients at risk of developing premature amniotic fluid outflow in comparison with the control group. An important role in the remodeling of the intercellular space of blood vessels is played by matrix metalloproteinases. A significant increase in the content of MMP-1 as the main enzyme was 2.5 times, MMP-3 was 4.9 times, MMP-9 was 1.5 times, and the concentration of TIMP-1 was 0.8 times lower compared to the control group. Another indicator may be the indicator of fetal fibronectin determined in the vaginal secretion, which in 66% of cases was positive.
Downloads
References
[1] Melissa M. Adams, Ph.D., Laurie D., et al. Rates of and factors associated with recurrence of preterm
delivery.//JAMA.- 2012.- 12.—1591–1596.
[2] Olenev A.S., D.I. Kryuchkova [et al.] // Vestnik RUDN. Ser .: Medicine. - 2016. - No. 3. - C. 110-115.
[3] M., Romero R., Park J.W. et al. The significance of a positive Amnisure test (™) in women with
preterm labor and intact membranes. J. Matern. Fetal Neonatal Med. 2012; 25 (9): 1690–1698.
[4] Glukhova TN, Salov IA, Arzhaeva IA Risk factors for premature outflow of amniotic fluid in first pregnant
women // Fundamental research. 2011. No. 11. P. 30-32.
[5] Duda V.I., et al. Practical obstetrics. Minsk, 201232
[6] Kiseleva E. P., Krylov A. V., Starikova E. A., Kuznetsova S. A. Vascular endothelial growth factor and
immune system. Successes of modern biology. 2009; 129 (4): vv 1–12.
[7] Gomez-Lopez N., Hernandez-Santiago S., Lobb A.P., et al. Normal and Premature rupture of Fetal
Membranes at Term Delivery Differ in Regional Chemotactic Activity and Related Chemokine. Cytokine
Production // Rep. Science. - 2013 .-- Vol. 20. Number 3. - P. 276-284
[8] Aksenenko, M. B. Assessing the relationship of inhibition of matrix metalloproteinase-9 and the content of
collagen fibers in various organs / M. B. Aksenenko, T. G. Ruksha // Siberian honey journal - 2013. - No.
2. - S. 56-58.
[9] Kulakova Premature rupture of the membranes (Premature outflow of water): clinic. management /
FSBI “Scientific Center of Obstetrics, Gynecology, and Perinatology.” - M.:B. and.], 2013. - 35 p.
[10] Markelova E.V., Zdor V.V., Romanchuk L. - Matrix metalloproteinases: their relationship with the
cytokine system, diagnostic and prognostic potential /// Immunopathology, allergology, infectology. - 2016.
- No. 2. - S. 11-22.
[11] Radzinsky V.E., Ordiyants I.M., Aleev I.A. Premature rupture of the membranes. Modern approaches to
diagnosis and treatment.—M.: Media Bureau Status Praesens, 2011.
[12] Rogova L.N., Shesternina N.V., Zametnik T.V. - Matrix metalloproteinases, their role in physiological and
pathological processes (review) Vest. new honey. technol. - 2011. - T. 18, No. 2. - S. 86-89.
[13] S ACOG Committee on Practice Bulletins-Obstetrics. Clinical management guidelines for obstetrician-gynecologists. (ACOG Practice Bulletin No. 160: premature rupture of membranes) Obstet. Gynecol.
2016; 127.
[14] Fortunato S. J., Menon R. J. Screening of novel matrix metalloproteinases (MMPs) in human fetal
membranes. AssistReprodGenet. 2012; 19 (10): 483–486.
[15] Fortunato S.J. et al. // Am. J. Obstet. Gynecol.—2006, Vol. 175, No. 4.—P. 1057-1065.
[16] Goya M., Pratcorona L., Merced C., et al. Cervical pessary in pregnant women with a short cervix (PECEP):
an open-label randomized controlled trial // Lancet. - 2012. - Vol. 379. - P. 1800-1806.
[17] Hermanns-Lê T., Pierard G. E. Collagen fibril arabesques in connective tissue disorders. Am. J. Clin. Dermatol. 2016.
[18] Lee S. S., Kan E., Sannikova V., Donnikov E., Klimantsev V., Amiraslanov ., Lomova A., Kesova I., Kostin P. A., Tyutyunnik L., Sukhikh G. Clinical and molecular genetic risk factors for premature rupture of membranes // Obstetrics and Gynecology. 2013. No. 4. P. 14-28.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
